Lunai Bioworks Inc (RENB)

Form DEF 14A - Other definitive proxy statements

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Lunai Bioworks Advances Biomarker Discovery Preclinical Program in Parkinson's Disease, Positioning for Strategic Pharma Partnerships

NEW YORK CITY, NEW YORK / ACCESS Newswire / September 25, 2025 / Lunai Bioworks Inc. (NASDAQ:RENB), an AI-powered drug discovery company and...

Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split

Measure taken to Comply with Nasdaq Rule 5550(a)(2) Regarding Minimum Bid Price LOS ANGELES, CA / ACCESS Newswire / September 24, 2025 / Lunai...

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form DEF 14A - Other definitive proxy statements

AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks

AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks PR...

AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks

AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks PR...

Form 8-K - Current report

Form PRE 14A - Other preliminary proxy statements